Skip to content
Insider tapeFilings through Fri, Nov 20
My stocks

Joseph W. Laplume

At a glance: Joseph W. Laplume is Evp, Corp Strategy & Develop at Charles River Laboratories (CRL). Their latest SEC Form 4, filed Mar 4, 2026, reported a purchase of $4K. On file: 1 purchase line ($4K) and 1 sale line ($65K).

Disclosed holdings: about $8.6M of CRL stock: 27,448 shares reported on their latest Form 4 (filed Mar 4, 2026), valued at the Nov 20, 2026 close of $314.32. This counts only CRL shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Evp, Corp Strategy & Develop at Charles River Laboratories International, Inc. (CRL)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$3K
Total bought / sold$4K / $65K

Joseph W. Laplume's InsiderPrint

2 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.

InsiderPrint of Joseph W. Laplume: 2 trades, 2025 to 20262025: 0 buys, 1 sale2026: 1 buy, 0 sales
  • Bump outward: a purchase (1)
  • Dent inward: a sale (1)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Reported trades

Filed Stock Type Shares Price Value Since
Mar 4SEC CRLCharles River Laboratories International, Inc.First buy Buy 2527,448 held (+0%) $174.54 $4K +80.1%
Jan 20SEC CRLCharles River Laboratories International, Inc. Sell 40023,716 held (−2%) $163.72 $65K +92.0%
  • Buy

    Evp, Corp Strategy & Develop Joseph W Laplume bought $4K of CRL at $174.54 — first open-market purchase in our records.

Follow Joseph W. Laplume

Get one email when Joseph W. Laplume files a new purchase or sale. Free.

At most one email a day about Joseph W. Laplume, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.